The incidence of high-risk HPV infections in Slovakia at the start of the national organized screening for cervical cancer

被引:0
作者
Kudela, Erik [1 ]
Berakova, Katarina [2 ]
Rokos, Tomas [1 ]
Kozubik, Erik [1 ]
Pribulova, Terezia [1 ]
Biringer, Kamil [1 ]
Grendar, Marian [3 ]
机构
[1] Comenius Univ, Jessenius Fac Med Martin, Clin Gynecol & Obstet, Martin 03601, Slovakia
[2] Martinske Biopticke Ctr Sro, Zilina 01001, Slovakia
[3] Comenius Univ, Jessenius Fac Med Martin, Biomed Ctr, Martin 03601, Slovakia
关键词
HPV; Screening; Cytology; Vaccination; Cervical cancer; WOMEN; CYTOLOGY; METAANALYSIS; PREVALENCE; GRADE; MANAGEMENT; TRIAGE; CELLS;
D O I
10.1186/s13027-025-00675-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective Until now, Slovakia has lacked complex data regarding the prevalence of specific high-risk HPV types in female population. Accordingly, our study focused on the population of Northern Slovakia, providing valuable insights into the correlation between cytological diagnoses, age, and HPV prevalence. Methods We performed a retrospective analysis of results from cytological cervical cancer screening and HPV DNA testing in 2023 involving 74,850 women in the Zilina region of northern Slovakia. Results The most common HPV infection based on the results of the HPV DNA testing was the group positivity for other high-risk HPVs at 17.73%, followed by HPV16 (6.03%) and HPV18 (1.57%) positivity.The overall HPV DNA positivity, regardless of age, was 21.59%. We observed a significant decrease in high-risk HPV prevalence with increasing age (p < 0.001), with the highest values in the age group of 18-25 years (37.92%). A second peak of high-risk HPV infection was observed in the age group of 51-55 years. HPV coinfection, defined as a combination of positive HPV DNA test results, was observed in 3.49% of cases (187/5,354). Conclusion We found relatively high prevalence of high-risk HPV types in Slovak population. Our findings may serve as a valuable baseline for future evaluations of the impact of both organized screening and vaccination in the country.
引用
收藏
页数:10
相关论文
共 40 条
[21]   High-risk HPV prevalence in the Czech cervical cancer screening population: a comparison of clinician-collected and self-collected sampling [J].
Jaworek, Hana ;
Bouska, Ondrej ;
Kourilova, Pavla ;
Hajduch, Marian ;
Koudelakova, Vladimira .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2025,
[22]  
Kedzia W, 2010, GINEKOL POL, V81, P740
[23]  
Kedzia W, 2010, GINEKOL POL, V81, P664
[24]   Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women [J].
Kjaer, Susanne K. ;
Falkenthal, Thea E. Hetland ;
Sundstroem, Karin ;
Munk, Christian ;
Sture, Tina ;
Bautista, Oliver ;
Rawat, Sonali ;
Luxembourg, Alain .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
[25]   Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans [J].
Maver, P. J. ;
Poljak, M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2020, 26 (05) :579-583
[26]  
Nayar R., 2015, The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes, DOI DOI 10.1007/978-3-319-11074-5
[27]  
nczisk, Ockovanie deti proti virusu HPV
[28]  
noisk, Home
[29]   Global prevalence of cervical human papillomavirus in women aged 50 years and older with normal cytology: a systematic review and meta-analysis [J].
Osmani, Vanesa ;
Hoerner, Lucy ;
Nkurunziza, Theoneste ;
Rank, Sophia ;
Tanaka, Luana Fiengo ;
Klug, Stefanie J. .
LANCET MICROBE, 2025, 6 (01)
[30]   Divergent effects of switching from cytology to HPV-based screening in the Nordic countries [J].
Partanen, Veli-Matti ;
Dillner, Joakim ;
Trope, Ameli ;
Agustsson, Agust Ingi ;
Lonnberg, Stefan ;
Heinavaara, Sirpa ;
Anttila, Ahti .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34 (02) :354-360